stacey, Author at Chemence Medical, Inc.

Feb

International Women in Science Day: From Curiosity to Innovation

stacey | February 10, 2026

Deanna Kathumbi-Jackson’s Journey in Science and Technology For Deanna Kathumbi-Jackson, Chief Technology Officer at Chemence Medical, a lifelong passion for science and innovation began in an unexpected place television. Growing up, Deanna was fascinated by shows like The Six Million Dollar Man and The Bionic Woman. While she didn’t yet have the language for … International Women in Science Day: From Curiosity to Innovation

Purple and white tube of topical skin adhesive named Derma+Flex QS. Text explaining 10 day microbial barrier.

Jan

Derma+Flex QS Extended Microbial Barrier

stacey | January 29, 2026

DermaFlex® QS: A Strong Seal with a 10-Day Microbial Barrier DermaFlex® QS is a high-performance topical skin adhesive designed to support wound closure while simplifying post-procedure care. Once applied, it forms a flexible, waterproof seal that naturally sloughs off as the skin heals—eliminating the need for follow-up visits related to adhesive removal. What sets DermaFlex … Derma+Flex QS Extended Microbial Barrier

Jan

2026 First Glimpse at 2026 Events

stacey | January 2, 2026

✈️ Chemence Medical | First Glimpse at 2026 Events Calendar We’re gearing up for a busy year of collaboration, innovation, and connection across the healthcare supply chain. Catch Chemence Medical at these upcoming industry events: Federation of American Hospitals Conference & Business Exposition 🗓 February 23–25, 2026 📍 Las Vegas, NV Spring IDN Summit & … 2026 First Glimpse at 2026 Events

Oct

Chemence Team Exhibits at CPHI Milan October 8-10th

stacey | October 1, 2024

Exciting news! 🌍 Chemence, the world leader in topical skin adhesives, will be at the 35th annual CPHI show in Milan next week. Chemence joins 2,400 exhibitors in welcoming over 62,000 visitors to this event. Join us in advancing human health. Visit booth 10D42 to explore our latest innovations in medical adhesive solutions. For 20 … Chemence Team Exhibits at CPHI Milan October 8-10th

Jan

Chemence Medical Received FDA Approval for exofin Precision Pen

stacey | January 31, 2022

January 31, 2022 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell the Exofin® Precision Pen as a new medical device for wound closure. The Exofin Precision Pen will enable medical providers greater versatility and exactness in closing wounds while also … Chemence Medical Received FDA Approval for exofin Precision Pen